{"slideshow_credits": null, "snippet": "The latest cash-and-stock bid \u201csubstantially undervalues\u201d Allergan and \u201ccreates significant risks and uncertainties\u201d for its shareholders, the chief executive said in a letter.", "abstract": "The latest cash-and-stock bid \u201csubstantially undervalues\u201d Allergan and \u201ccreates significant risks and uncertainties\u201d for its shareholders, the chief executive said in a letter.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES"}, "web_url": "http://dealbook.nytimes.com/2014/06/10/allergan-rejects-valeants-53-billion-offer/", "lead_paragraph": null, "headline": {"main": "Allergan, Maker of Botox, Rejects Valeant's $53 Billion Offer", "print_headline": "Rejected, Again", "kicker": "DealBook"}, "_id": "5397020638f0d87e74647ffe", "word_count": "696", "multimedia": [{"height": 126, "url": "images/2014/05/28/business/dbpix-allergan2/dbpix-allergan2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/05/28/business/dbpix-allergan2/dbpix-allergan2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 410, "url": "images/2014/06/10/business/dealbook/dbpix-pyott/dbpix-pyott-articleLarge-v2.jpg", "legacy": {"xlarge": "images/2014/06/10/business/dealbook/dbpix-pyott/dbpix-pyott-articleLarge-v2.jpg", "xlargewidth": "600", "xlargeheight": "410"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/05/28/business/dbpix-allergan2/dbpix-allergan2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/05/28/business/dbpix-allergan2/dbpix-allergan2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-06-10T09:01:45Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Ackman, William A", "rank": "1"}, {"name": "persons", "value": "Pearson, Michael", "rank": "2"}, {"name": "persons", "value": "Pyott, David E I", "rank": "3"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": "2"}, {"name": "organizations", "value": "Allergan Inc", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}